Lola Eniola-Adefeso

Last updated
Lola Eniola-Adefeso
Lola Eniola-Adefeso in Findings Magazine 01.png
Eniola-Adefeso in NIGMS Findings Magazine, 2009
Born
Maryland, USA
Alma mater University of Maryland, Baltimore County
University of Pennsylvania
Scientific career
Institutions University of Illinois Chicago

University of Michigan

Baylor College of Medicine
Website https://che.engin.umich.edu/people/lola-eniola-adefeso/

Omolola (Lola) Eniola-Adefeso is a Nigerian-American chemical engineer and incoming Dean of the College of Engineering at the University of Illinois Chicago. [1]

Contents

She is currently the Vennema Endowed Professor of Chemical Engineering, the Associate Dean for Graduate and Professional Education, and University Diversity and Social Transformation Professor of Chemical Engineering, Biomedical Engineering, and Macromolecular Science and Engineering at the University of Michigan College of Engineering. [2]

Eniola-Adefeso is also a co-founder and chief scientific officer of Asalyxa Bio. Her research looks to design biocompatible functional particles for targeted drug delivery.

Education

Eniola-Adefeso moved to Maryland from Nigeria at the age of 16. [3] She was going to attend medical school but became interested in chemical engineering. [4] Eniola-Adefeso studied Chemical and Biomolecular Engineering at University of Maryland, Baltimore County, graduating in 1999. [5] She moved to University of Pennsylvania for her postgraduate studies, graduating in 2004. [5] [6]

Career

Scientific impact

Eniola-Adefeso in NIGMS Findings Magazine, 2009. Lola Eniola-Adefeso in Findings Magazine 02.png
Eniola-Adefeso in NIGMS Findings Magazine, 2009.

After completing her graduate studies, Eniola-Adefeso worked in the Baylor College of Medicine as a National Institutes of Health postdoctoral fellow. [7] [8] Eniola-Adefeso joined University of Michigan in 2006. [9] In 2013, she was named a Miller Faculty Scholar at the University of Michigan and now also serves as the associate dean for graduate and professional education in the college of engineering. [10] [11] [12] [13] She is interested in the interactions between blood leukocytes and endothelial cells in vessel lumen lining, and how they change during inflammation response. [8] [14] After losing her father to heart disease, Eniola-Adefeso began to research new treatments for it. [15] [16]

Eniola-Adefeso’s research has focused on leveraging hemodynamics to design novel, vascular-targeted particle therapies. Repeatedly challenging the status quo, she has published a multitude of game-changing “firsts” in the field. Publications from her lab were the first to demonstrate that nanoparticles' size, shape, and density – acting as “vascular-targeting drug carriers (VTCs)”- matter in their ability to reach and bind the blood vessel wall. This bold body of work has been instrumental in “redefining the problem” of advancing the development of novel controlled delivery solutions to vascular diseases and is catalyzing novel solutions. Her lab’s systematic use of ex vivo models of human microvessels and blood flows, followed closely with in vivo assays in mice, sensitized the biomedical engineering field to recognizing “blood as a tissue” with distinct features across species.

Her lab has since leveraged its models to reveal new information about neutrophils (PMNs) and their interactions with VTCs. They provided the first evidence of circulating PMNs rapidly binding and phagocytosing particles within minutes. [17] This landmark observation paved the way for her lab’s interest in particle-based immunomodulation of PMNs in acute and chronic inflammatory conditions.

Eniola-Adefeso always aims to leverage fundamental science discovery in her lab toward clinical applications. In this vein, she demonstrated in a Science Advances publication from 2020 that human neutrophils prefer to phagocytose (i.e., eat) rod-shaped particles, which is counter to the widely accepted notion in the literature – primarily based on work with mouse blood and cell lines – that blood phagocytes do not effectively eat rods. [18] This revelation offers a novel approach to targeting neutrophils in numerous diseases.

Her critical discovery, coupled with an innovative polymer, has led to the recent formation of a startup company, Asalyxa Bio, where Eniola-Adefeso holds the chief scientific officer position. [19] Since its incorporation in July, she has led the company to raise funds for a first-in-human clinical trial toward developing this technology to treat Acute Respiratory Distress Syndrome (ARDS).

Eniola-Adefeso is a Fellow of the American Institute for Medical and Biological Engineers (AIMBE) and Biomedical Engineering Society (BMES). She serves as a deputy editor for Science Advances, on the board of directors for AICHE and AIMBE, and as a member of the external advisory board for the biomedical engineering department at the University of Florida and Boston University.

Diversity, equity, and inclusion work

Eniola-Adefeso is a champion for women and underrepresented minority students within University of Michigan. [20] She has established a mentoring scheme and served as graduate chair, recruiting the most diverse cohort of students in the department's history. [21] [20] She encouraged undergraduate students to develop experiments for K-12 teachers to use in their classrooms. [20] Eniola-Adefeso has been involved in the College of Engineering NextProf program, which brings women and minority students to campus to experience academic life. [20] In 2018, along with Professor Chinedum Okwudire, she co-established the NextProf Pathfinder Workshop, [22] a future-faculty program specifically aimed at first- and second-year PhD students, rather than final year PhD students and postdoctoral fellows, as is typical in many other institutions. The goal of the NextProf Pathfinder Workshop is to equip the attendees – mostly women and students from underrepresented groups – with the knowledge and skills needed to develop strong CVs, early in their PhD process, to make them competitive for faculty positions. The NextProf Pathfinder program has now expanded to include the University of California, San Diego and the Georgia Institute of Technology.

In 2021, Eniola-Adefeso and BME colleagues from many US institutions called out racial funding disparity by the National Institutes of Health garnering support for these larger institutional DEI changes from both academic and non-academic communities. [23] The paper and the national advocacy effort led by Eniola-Adefeso led the NIH Director to publicly apologize for ‘structural racism,’ in NIH funding and pledges actions”. [24]

Honors and fellowships

Select publications

Related Research Articles

<span class="mw-page-title-main">American Institute for Medical and Biological Engineering</span> Non-profit organization

The American Institute for Medical and Biological Engineering (AIMBE) is a non-profit organization founded in 1991, and headquartered in Washington, D.C. It represents 50,000 medical and biomedical engineers, and academic institutions, private industry, and professional engineering societies.

<span class="mw-page-title-main">Ravi V. Bellamkonda</span> Indian-American biomedical engineer

Ravi V. Bellamkonda is an Indian-American biomedical engineer and academic administrator. Since 2021, he has served as Provost and Executive Vice President for Academic Affairs at Emory University in Atlanta, Georgia. Bellamkonda was previously Vinik Dean of the Pratt School of Engineering at Duke University. Pending approval by the Board of Trustees, he will serve as Provost and Executive Vice President for Academic Affairs at The Ohio State University in Columbus, Ohio, effective January 14, 2025.

Mingyan Liu is an electrical engineering and computer science professor, and the Peter and Evelyn Fuss Chair of Electrical and Computer Engineering at the University of Michigan, Ann Arbor, MI. Her research is in optimal resource allocation, sequential decision theory, incentive design, online learning, and modeling and mining of large scale Internet measurement data concerning cyber security. She was a co-founder of the cybersecurity scoring startup Quadmetrics in 2014. Quadmetrics was named a "2016 Cool Vendor in Risk Management" by Gartner, and was acquired by FICO in 2016.

Douglas C. Noll is an American bioengineer currently the Ann and Robert H. Lurie Professor of Bioengineering at University of Michigan, where he also is professor of radiology and co-director of the Functional MRI Laboratory.

Martha Gray is a biomedical engineer and professor at the Massachusetts Institute of Technology, jointly appointed in the Department of Electrical Engineering and Health Sciences and Technology (HST). Gray became the first woman to lead a department of science or engineering at MIT when she became the co-director of the Harvard–MIT Program of Health Sciences and Technology in 1987. She has developed multidisciplinary programs at MIT. Her research focuses on understanding and preventing Osteoarthritis, and her team developed the imaging technology dGEMRIC, now used to examine cartilage.

<span class="mw-page-title-main">Akhilesh K. Gaharwar</span> Indian biomedical engineering researcher (born 1982)

Akhilesh K. Gaharwar is an Indian academic and a professor in the Department of Biomedical Engineering at Texas A&M University.

Elizabeth M. C. Hillman is a British-born academic who is Professor of Biomedical Engineering and Radiology at Columbia University. She was awarded the 2011 Adolph Lomb Medal from The Optical Society and the 2018 SPIE Biophotonics Technology Innovator Award.

Guillermo Antonio Ameer is the Daniel Hale Williams Professor of biomedical engineering at the Robert R. McCormick School of Engineering and Applied Science and Surgery at the Feinberg School of Medicine of Northwestern University and is a fellow of the American Institute for Medical and Biological Engineering, Biomedical Engineering Society, American Institute of Chemical Engineers, American Association for the Advancement of Science, Materials Research Society, and American Academy of Arts and Sciences. He is an engineer, inventor, and entrepreneur.

<span class="mw-page-title-main">Erin Lavik</span> American material scientist

Erin Baker Lavik is an American bioengineer serving as the deputy director and chief technology officer of the National Cancer Institute's Division of Cancer Prevention (DCP) since 2023. She was previously a professor of chemical, biochemical, and environmental engineering at the University of Maryland, Baltimore County. Lavik develops polymers and nanoparticles that can protect the nervous system. She is a fellow of the American Institute for Medical and Biological Engineering.

<span class="mw-page-title-main">Chinedum Okwudire</span> American academic in the field of engineering

Chinedum (Chi) Okwudire is a Nigerian-American mechanical engineer and a professor of Mechanical Engineering and Miller Faculty Scholar at the University of Michigan, where he directs the Smart and Sustainable Automation Research Lab. He is also the founder and chief technology officer of Ulendo Technologies, Inc. His research is in the area of manufacturing automation, control engineering, and mechatronics.

Christine E. Schmidt is an American biomedical engineer. As a professor at the University of Florida, Schmidt was inducted into the Florida Inventors Hall of Fame for her creation of the Avance Nerve Graft which has "improved the lives of numerous patients suffering from peripheral nerve damage." In 2024, Schmidt was elected to both the National Academy of Engineering and the National Academy of Medicine.

<span class="mw-page-title-main">David Vorp</span>

David A. Vorp is an American bioengineer, researcher, entrepreneur, and academic administrator noted for his contributions to aortic aneurysm biomechanics and pathobiology, and tissue engineered vascular grafts. He currently holds the titles of Associate Dean for Research at the University of Pittsburgh Swanson School of Engineering and the John A. Swanson Professor of Bioengineering, with secondary appointments in the departments of Cardiothoracic Surgery, Surgery, Chemical & Petroleum Engineering, and the Clinical & Translational Sciences Institute at the University of Pittsburgh. He also serves as the co-director of the Center for Medical Innovation., the acting director of the university's GRID Institute, and the director of the Vascular Bioengineering Laboratory.

Elizabeth Cosgriff-Hernandez is an American biomedical engineer who is a professor at the University of Texas at Austin. Her work involves the development of polymeric biomaterials for medical devices and tissue regeneration. She is a co-founder of Rhythio Medical, on the scientific advisory board of ECM Biosurgery, and a consultant to several companies on biostability evaluation of medical devices. Dr. Cosgriff-Hernandez is an associate editor of the Journal of Materials Chemistry B and Fellow of the International Union of Societies for Biomaterials Science and Engineering, Biomedical Engineering Society, Tissue Engineering and Regenerative Medicine International Society, American Chemical Society Division of Polymeric Materials: Science and Engineering, Royal Society of Chemistry, and the American Institute for Medical and Biological Engineering.

Charles Wyatt Shields IV is an American biomedical engineer and assistant professor at the University of Colorado Boulder in the Department of Chemical and Biological Engineering. His research involves the rational design of colloidal and supracolloidal particles for applications in drug delivery and biosensing.

Cynthia "Cindy" Reinhart-King is an American biomedical engineer and Department Chair of Bioengineering at Rice University. Her research considers cell motility and adhesion. She serves as president of the Biomedical Engineering Society.

Claudia Fischbach is a German bioengineer who serves as the James M. and Marsha McCormick Director of Biomedical Engineering and the Stanley Bryer 1946 Professor of Biomedical Engineering at Cornell University. She is Director of the Cornell Physical Sciences Oncology Center on the Physics of Cancer Metabolism.

<span class="mw-page-title-main">Juergen Hahn</span> American university professor

Juergen Hahn is an American engineering professor. His research focuses on computational systems biology with a specific emphasis on the development of data science approaches and their application to biological pathways relevant to the life sciences.

Nozomi Nishimura is an American biomedical engineer who is an associate professor at Cornell University. She was awarded the L'Oréal for Women in Science Fellowship in 2009 and was inducted into the 2024 Class of the AIMBE College of Fellows for her research in intravital microscopy contributing to the understanding of microscale physiology.

Cynthia (Cindy) Chestek is an American biomedical engineer and Associate Professor of Bioengineering and Neuroscience at the University of Michigan. Chestek is currently an Associate Chair of Research for Biomedical Engineering in the College of Engineering at University of Michigan where she studies brain and nerve control of finger movements, as well as high-density carbon fiber electrode arrays. She is also an associate professor for robotics, biomedical engineering, electrical engineering and computer science.

Janie McLawhorn Fouke is an American biomedical engineer known for her work in airway physiology and academic leadership.

References

  1. "Lola Eniola-Adefeso named College of Engineering dean | UIC today". today.uic.edu. Retrieved 2024-07-16.
  2. "Lola Eniola-Adefeso". Chemical Engineering. Retrieved 2024-07-16.
  3. "Highways to Healing – Omolola Eniola-Adefeso '99, ChemEng". 2 September 2011.
  4. 1 2 "Meyerhoff Scholar – News and Stories for UMBC Alumni". umbcalumni.wordpress.com. Retrieved 2018-05-09.
  5. 1 2 "Lola Eniola-Adefeso – Chemical Engineering". che.engin.umich.edu. Retrieved 2018-05-09.
  6. "CBE – Lola Eniola-Adefeso, ChE PhD'04 Elected to the College of Fellows at AIMBE". www.cbe.seas.upenn.edu. Retrieved 2018-05-09.
  7. "Diversity Program Alumni Updates: Omolola Eniola-Adefeso, Ph.D. – National Institute of General Medical Sciences". www.nigms.nih.gov. Retrieved 2018-05-09.
  8. 1 2 "Omolola Eniola-Adefeso, PhD". Michigan Center for Integrative Research in Critical Care. Retrieved 2018-05-09.
  9. 1 2 "Eniola Adefeso receives University honor and promotion to professor | Michigan Engineering". Michigan Engineering. Retrieved 2018-05-09.
  10. "Lola Eniola-Adefeso – Chemical Engineering". che.engin.umich.edu. Retrieved 2021-02-26.
  11. 1 2 "Lola Eniola-Adefeso elected fellow of AIMBE | Michigan Engineering". Michigan Engineering. Retrieved 2018-05-09.
  12. "Alumni Promotions and Awards" (PDF). University of Penn. Retrieved 2018-05-09.
  13. "Lola Eniola-Adefeso promoted to associate professor | Michigan Engineering". Michigan Engineering. Retrieved 2018-05-09.
  14. "UMBC Meyerhoff Scholars Program". www.umbc.edu. Retrieved 2018-05-09.
  15. NIGMS (2010-09-10), NIGMS Grantee Dr. Lola Eniola-Adefeso on Developing New Heart Disease Drugs , retrieved 2018-05-09
  16. "Special Delivery – September 2009 – Findings – Science Publication – National Institute of General Medical Sciences". publications.nigms.nih.gov. Retrieved 2018-05-09.
  17. Fromen, Catherine A.; Kelley, William J.; Fish, Margaret B.; Adili, Reheman; Noble, Jeffery; Hoenerhoff, Mark J.; Holinstat, Michael; Eniola-Adefeso, Omolola (November 28, 2017). "Neutrophil–Particle Interactions in Blood Circulation Drive Particle Clearance and Alter Neutrophil Responses in Acute Inflammation". ACS Nano. 11 (11): 10797–10807. doi:10.1021/acsnano.7b03190. PMC   5709153 . PMID   29028303.
  18. Safari, Hanieh; Kelley, William J.; Saito, Eiji; Kaczorowski, Nicholas; Carethers, Lauren; Shea, Lonnie D.; Eniola-Adefeso, Omolola (2020-06-12). "Neutrophils preferentially phagocytose elongated particles—An opportunity for selective targeting in acute inflammatory diseases". Science Advances. 6 (24): eaba1474. doi:10.1126/sciadv.aba1474. ISSN   2375-2548. PMC   7286665 . PMID   32577517.
  19. "Biotech | Orange Grove Bio Team". Asalyxa. Retrieved 2021-02-27.
  20. 1 2 3 4 5 "Eniola-Adefeso wins College of Engineering award | Michigan Engineering". Michigan Engineering. Retrieved 2018-05-09.
  21. "Mentoring Moment with Dr. Lola Eniola-Adefeso (UMBC Alum)". myUMBC. Retrieved 2018-05-09.
  22. "NextProf Pathfinder". nextprofpathfinder.engin.umich.edu. Retrieved 2023-10-06.
  23. Stevens, Kelly R.; Masters, Kristyn S.; Imoukhuede, P.I.; Haynes, Karmella A.; Setton, Lori A.; Cosgriff-Hernandez, Elizabeth; Lediju Bell, Muyinatu A.; Rangamani, Padmini; Sakiyama-Elbert, Shelly E.; Finley, Stacey D.; Willits, Rebecca K.; Koppes, Abigail N.; Chesler, Naomi C.; Christman, Karen L.; Allen, Josephine B.; Wong, Joyce Y.; El-Samad, Hana; Desai, Tejal A.; Eniola-Adefeso, Omolola (2021-02-04). "Fund Black scientists". Cell. 184 (3): 561–565. doi:10.1016/j.cell.2021.01.011. ISSN   0092-8674. PMID   33503447.
  24. "NIH director apologizes for 'structural racism,' pledges actions". www.science.org.
  25. MLK Visiting Professorship, MIT
  26. "Biomedical Engineering Society".
  27. "BMES Mid-Career Award".
  28. Scholars, The Community of. "1,000 inspiring Black scientists in America". crosstalk.cell.com.
  29. "Eniola-Adefeso Lab Group Website". cheresearch.engin.umich.edu.
  30. "Office of the Provost | Harold R. Johnson Diversity Service Award". www.provost.umich.edu. Retrieved 2018-05-09.
  31. "NSF Award Search: Award#1054352 – CAREER: Defining the interplay between hemodynamics and shape/size in particle localization to the vascular wall – an integrated in vitro and in vivo study". www.nsf.gov. Retrieved 2018-05-09.
  32. "Lola Eniola-Adefeso". www.aiche.org. 29 August 2017. Retrieved 2018-05-09.
  33. 1 2 3 "Eniola Research Group – Cell Adhesion & Drug Delivery". cheresearch.engin.umich.edu. Retrieved 2018-05-09.